Jiří Piťha

2.2k total citations
32 papers, 357 citations indexed

About

Jiří Piťha is a scholar working on Neurology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Jiří Piťha has authored 32 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 7 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in Jiří Piťha's work include Myasthenia Gravis and Thymoma (14 papers), Peripheral Neuropathies and Disorders (9 papers) and Multiple Sclerosis Research Studies (6 papers). Jiří Piťha is often cited by papers focused on Myasthenia Gravis and Thymoma (14 papers), Peripheral Neuropathies and Disorders (9 papers) and Multiple Sclerosis Research Studies (6 papers). Jiří Piťha collaborates with scholars based in Czechia, Netherlands and Israel. Jiří Piťha's co-authors include Eva Havrdová, Tomáš Kozák, Robert Pytlík, Jacqueline Maaloufová, Petr Kobylka, Helena Marečková, Michala Jakubíková, Aleš Bartoš, I Malbohán and Jaromír Kukal and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of the Neurological Sciences.

In The Last Decade

Jiří Piťha

22 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiří Piťha Czechia 10 147 143 64 56 48 32 357
D. Reske Germany 8 117 0.8× 63 0.4× 40 0.6× 22 0.4× 49 1.0× 18 264
Zhifeng Mao China 13 208 1.4× 302 2.1× 86 1.3× 16 0.3× 81 1.7× 25 533
F. Pagliai Italy 8 167 1.1× 35 0.2× 62 1.0× 68 1.2× 49 1.0× 11 284
Nikolitsa Kafasi Greece 8 69 0.5× 98 0.7× 45 0.7× 102 1.8× 22 0.5× 14 311
Eva Simmons-OʼBrien United States 6 54 0.4× 86 0.6× 182 2.8× 112 2.0× 58 1.2× 7 429
Teresa Bagulho United States 5 385 2.6× 146 1.0× 172 2.7× 56 1.0× 76 1.6× 7 489
Pierluigi Marradi Italy 12 71 0.5× 69 0.5× 91 1.4× 103 1.8× 19 0.4× 22 377
Léna Absi France 13 38 0.3× 329 2.3× 39 0.6× 127 2.3× 116 2.4× 25 625
Evripidis Kaltsonoudis Greece 11 75 0.5× 87 0.6× 27 0.4× 67 1.2× 156 3.3× 25 426
Cristina Valencia-Sánchez United States 12 116 0.8× 239 1.7× 72 1.1× 9 0.2× 19 0.4× 30 379

Countries citing papers authored by Jiří Piťha

Since Specialization
Citations

This map shows the geographic impact of Jiří Piťha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiří Piťha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiří Piťha more than expected).

Fields of papers citing papers by Jiří Piťha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiří Piťha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiří Piťha. The network helps show where Jiří Piťha may publish in the future.

Co-authorship network of co-authors of Jiří Piťha

This figure shows the co-authorship network connecting the top 25 collaborators of Jiří Piťha. A scholar is included among the top collaborators of Jiří Piťha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiří Piťha. Jiří Piťha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tichopád, Aleš, Jana Junkerová, Michala Jakubíková, et al.. (2024). Burden of Myasthenia Gravis in the Czech Republic: Analysis of the Nationwide Patient Registry. Neurology and Therapy. 14(1). 227–242.
2.
Jakubíková, Michala, Michaela Týblová, Iveta Nováková, et al.. (2021). Predictive factors for a severe course of COVID‐19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival. European Journal of Neurology. 28(10). 3418–3425. 52 indexed citations
3.
Ehler, Edvard & Jiří Piťha. (2017). Myasthenia gravis with anti-MuSK antibodies. Neurologie pro praxi. 18(5). 314–317.
4.
Avidan, Nili, Frédérique Truffault, Elsebeth Staun-Ram, et al.. (2017). Methylome and transcriptome profiling in Myasthenia Gravis monozygotic twins. Journal of Autoimmunity. 82. 62–73. 21 indexed citations
5.
Piťha, Jiří. (2016). Strategy initiation of treatment for multiple sclerosis. Neurologie pro praxi. 17(4). 236–239.
6.
Piťha, Jiří. (2016). Cardiac function in hypertensive patients with metabolic syndrome and microalbuminuria. Neurologie pro praxi. 17(3). 95–99. 1 indexed citations
7.
Jakubíková, Michala, Jiří Piťha, Helena Marečková, et al.. (2015). Two-year outcome of thymectomy with or without immunosuppressive treatment in nonthymomatous myasthenia gravis and its effect on regulatory T cells. Journal of the Neurological Sciences. 358(1-2). 101–106. 7 indexed citations
8.
Piťha, Jiří. (2014). Eskalace léčby pacienta s familiární roztroušenou sklerózou fingolimodem. Neurologie pro praxi. 15(5). 274–277.
9.
Piťha, Jiří, Josef Bednařík, Olga Zapletalová, et al.. (2012). Klinický standard pro diagnostiku a léčbu myasthenia gravis. Česká a slovenská neurologie a neurochirurgie. 1 indexed citations
10.
Bláha, M., Jiří Piťha, V. Bláha, et al.. (2011). Experience with extracorporeal elimination therapy in myasthenia gravis. Transfusion and Apheresis Science. 45(3). 251–256. 4 indexed citations
11.
Zámečnı́k, Josef, et al.. (2008). Atrophy of type II fibres in myasthenia gravis muscle in thymectomized patients: steroid‐induced change with prognostic impact. Journal of Cellular and Molecular Medicine. 13(8b). 2008–2018. 7 indexed citations
12.
Zámečnı́k, Josef, et al.. (2007). Muscle lymphocytic infiltrates in thymoma-associated myasthenia gravis are phenotypically different from those in polymyositis. Neuromuscular Disorders. 17(11-12). 935–942. 17 indexed citations
13.
Bartoš, Aleš, et al.. (2007). Elevated intrathecal antibodies against the medium neurofilament subunit in multiple sclerosis. Journal of Neurology. 254(1). 20–25. 46 indexed citations
14.
Bartoš, Aleš & Jiří Piťha. (2003). Opsoclonus—myoclonus—dysequilibriumsyndrome: cytological and immunological dynamics in the serialcerebrospinal fluid in two patients. Journal of Neurology. 250(12). 1420–1425. 3 indexed citations
15.
Zachoval, Roman, et al.. (2003). Augmentation Cystoplasty in Patients with Multiple Sclerosis. Urologia Internationalis. 70(1). 21–26. 28 indexed citations
16.
Kovář, J., et al.. (2002). The Effect of an Acute Fat Load on Endothelial Function after Different Dietary Regimens in Young Healthy Volunteers. Physiological Research. 51(1). 99–105. 17 indexed citations
17.
Kozák, Tomáš, Eva Havrdová, Jiří Piťha, et al.. (2001). Immunoablative therapy with autologous stem cell transplantation in the treatment of poor risk multiple sclerosis. Transplantation Proceedings. 33(3). 2179–2181. 22 indexed citations
18.
Piťha, Jiří, et al.. (2000). Variable Expression of Hypercholesterolemia in Apolipoprotein E2* (Arg136®Cys) Heterozygotes. Physiological Research. 307–314. 9 indexed citations
19.
Kozák, Tomáš, Eva Havrdová, Jiří Piťha, et al.. (2000). High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis. Bone Marrow Transplantation. 25(5). 525–531. 83 indexed citations
20.
Piťha, Jiří, et al.. (1966). [General argyrosis following esophagitis therapy].. PubMed. 15(2). 101–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Reske Breakdown of academic impact, for papers by Zhifeng Mao Breakdown of academic impact, for papers by F. Pagliai Breakdown of academic impact, for papers by Nikolitsa Kafasi Breakdown of academic impact, for papers by Eva Simmons-OʼBrien Breakdown of academic impact, for papers by Teresa Bagulho Breakdown of academic impact, for papers by Pierluigi Marradi Breakdown of academic impact, for papers by Léna Absi Breakdown of academic impact, for papers by Evripidis Kaltsonoudis Breakdown of academic impact, for papers by Cristina Valencia-Sánchez
Rankless by CCL
2026